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Figure S1
(A) Mouse fibroblast NIH3T3 cells stably overexpressing human EMSY. Cells were transfected with the indicated vectors. Cellular mRNA was isolated and the level of endogenous EMSY expression was measured by RT-qPCR. Gene expression change, normalized with respect to B2M, is presented as relative fold-change compared to the values of empty vector transfected cells (set at 1.0). Each value is the average of three independent experiments with error bars displaying S.D. of the mean.
(B) Characterization of the EMSY overexpression in human MCF-7 cells presented as in (A).
(C) Growth curve for MCF-7 cells overexpressing EMSY or empty vector. MCF-7 cells stably overexpressing EMSY or an empty vector were counted every 24 hours over for 5 days. The means of cell numbers are expressed as means +/-S.D. from triplicate wells. Experiment was repeated three times and the data from a representative experiment is shown. 
(B)
Correlation between EMSY and miR-31 expression in 98 tumours profiled by qPCR. Left: scatterplot illustrating the correlation between EMSY copy number (segmented mean) and EMSY expression for 98 tumours from the METABRIC cohort. Each point represents a tumour, which has been colored according to intrinsic subtype based on the PAM50 classifier. Right: scatterplot illustrating the anti-correlation between miR-31 and EMSY expression levels. Here, the correlation was evaluated using only the 85% (top 15%) of either EMSY or miR-31 expression levels as demarcated by dotted lines.
(C) A representative subset of 98 primary tumours was selected, and miR-31 expression levels were profiled by qPCR. Boxplots illustrating the distribution of miR-31 expression for EMSY amplified (AMP ; n=28 ; red) versus EMSY copy number neutral (NEUT ; n=30, blue) cases. miR-191 and miR-93 are used as controls. Wilcoxon rank sum test was used to evaluate whether expression levels varied significantly depending on EMSY copy number state.
(D) EMSY and miR-31 levels in mammary fat pad tumours. Tumours from the mammary fat pad experiment ( Figure 1C ) were collected and RNA was extracted using the miRVANA kit (Ambion), following manufacturer's instructions. The level of human EMSY and miR-31 expression was measured by RT-qPCR. Results were normalized to the B2M and RNAU5A for EMSY and miR-31 respectively. Each value is the average of two independent experiments. (A) Determination of the transcription start site for the primary transcripts of the miRNAs using 5' RACE. Total RNA extract from MCF-7 cells and was treated for GeneRacer PCR according to the manufacturer's protocol. After cloning and sequencing, the transcription start site was identified. These results are consistent with the mapped TSS available in the miRSTART database. (A) MCF-7 cells were transfected with each of the indicated siRNAs. Cellular mRNA was isolated and the levels of endogenous ETS-1, ETV4 (PEA3), and GATA1 expression were measured by RT-qPCR. Gene expression changes, normalized with respect to B2M, are presented as relative fold-change compared to the values of control-siRNA-treated cells (set at 1.0). Each value is the average of three independent experiments with error bars displaying S.D. of the mean.
(B) ETS-1 depletion does not affect EMSY expression. Endogenous EMSY is not affected by ETS-1 knockdown. EMSY expression was measured by RT-qPCR in MCF-7 cells depleted for ETS-1 (left panel). Gene expression changes, normalized with respect to B2M, are presented as relative fold-change compared to the values of control-siRNA-treated cells (set at 1.0). Right panel: representative Western blot analysis of EMSY expression in MCF-7 cells depleted for ETS-1. ß-tubulin was used as a loading control.
(C) Validation of the ChIP analyses with ETS-1 antibody. ChIP analysis of ETS-1 associated with the miR-31, miR-198, and miR-181a-2 promoters. MCF-7 cells were harvested, and used for ChIP experiments using anti-ETS-1 (white bars) or anti-GFP (black bars) antibodies. The precipitated DNA fragments were subjected to qPCR analysis with specific primers corresponding to 3 amplicons encompassing the regulatory region of each miRNA as indicated. ChIPs performed with anti-GFP serve as negative controls. The data have been normalized to "Input" amplification levels for each amplicon. The blot was then stripped and re-probed for ß-tubulin which was used as a loading control. Endogenous KDM5A and EMSY are not affected by KDM5B knockdown (right panel). Gene expression was measured by RT-qPCR in MCF-7 cells depleted for KDM5B. Gene expression changes, normalized with respect to B2M, are presented as relative fold-change compared to the values of control-siRNA-treated cells (set at 1.0). Each value is the average of three independent experiments with error bars displaying S.D. of the mean.
(E) Validation of the ChIP analyses with KDM5B antibody. ChIP analysis of KDM5B associated with the miR-31, miR-198, and miR-181a-2 promoters. MCF-7 cells were harvested, and used for ChIP experiments using anti-KDM5B (brown bars) or anti-GFP (white bars) antibodies. The precipitated DNA fragments were subjected to qPCR analysis with specific primers corresponding to 3 amplicons encompassing the regulatory region of each miRNA as indicated. ChIPs performed with anti-GFP serve as negative controls. The data have been normalized to "Input" amplification levels for each amplicon. Each amplicon was analysed in duplicate. Experiments were repeated at least two times with similar results. A representative example of a ChIP analysis is shown. Each amplicon was analysed in duplicate each time and error bars represent the standard deviation for each amplicon.
. Table S1 , Viré et al. Table 1 38 miRNAs are found significantly deregulated in MCF-7 cells depleted from EMSY (9 down-regulated in red and 29 up-regulated in green). The expression of 88 miRNAs known or predicted to alter their expression during breast cancer initiation/progression (Human Breast Cancer miScript miRNA PCR Array, Qiagen) was analysed by qPCR. Gene expression changes are ranked based on relative fold-change compared to the values of cells transfected with empty vector (set at 1.0). p-value is < 0.05. 
Supplementary

